Zydus Life jumps on USFDA nod for BP lowering drug

Zydus Lifesciences advanced 3.89% to Rs 1,137.20 after the drug maker received tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil tablets.